91 related articles for article (PubMed ID: 9972842)
1. The expression of behavioral sensitization to amphetamine: role of CCK(A) receptors.
DeSousa NJ; Wunderlich GR; De Cabo C; Vaccarino FJ
Pharmacol Biochem Behav; 1999 Jan; 62(1):31-7. PubMed ID: 9972842
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat.
Wunderlich GR; DeSousa NJ; Vaccarino FJ
Psychopharmacology (Berl); 2000 Aug; 151(2-3):283-90. PubMed ID: 10972475
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the contribution of CCKB receptor mechanisms to individual differences in amphetamine-induced locomotion.
Higgins GA; Sills TL; Tomkins DM; Sellers EM; Vaccarino FJ
Pharmacol Biochem Behav; 1994 Aug; 48(4):1019-24. PubMed ID: 7972279
[TBL] [Abstract][Full Text] [Related]
4. Effect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behavior and sensitization to amphetamine.
Alttoa A; Harro J
Eur Neuropsychopharmacol; 2004 Aug; 14(4):324-31. PubMed ID: 15163443
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.
Vasar E; Harro J; Lang A; Pôld A; Soosaar A
Psychopharmacology (Berl); 1991; 105(3):393-9. PubMed ID: 1798834
[TBL] [Abstract][Full Text] [Related]
6. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine.
Dietz DM; Tapocik J; Gaval-Cruz M; Kabbaj M
Physiol Behav; 2005 Oct; 86(3):347-55. PubMed ID: 16126238
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure.
Wunderlich GR; Rotzinger S; Bush DE; DeSousa NJ; Vaccarino FJ
Brain Res; 2004 Mar; 1001(1-2):95-107. PubMed ID: 14972658
[TBL] [Abstract][Full Text] [Related]
8. Role of D1-like receptors in amphetamine-induced behavioral sensitization: a study using D1A receptor knockout mice.
Karper PE; De la Rosa H; Newman ER; Krall CM; Nazarian A; McDougall SA; Crawford CA
Psychopharmacology (Berl); 2002 Feb; 159(4):407-14. PubMed ID: 11823893
[TBL] [Abstract][Full Text] [Related]
9. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of lesions in the subareas of medial prefrontal cortex on the development of behavioral sensitization to amphetamine: the role of environmental context.
Liao RM; Lin HL
Chin J Physiol; 2008 Dec; 51(6):394-401. PubMed ID: 19280884
[TBL] [Abstract][Full Text] [Related]
11. Individual differences in sugar intake predict the locomotor response to acute and repeated amphetamine administration.
Sills TL; Vaccarino FJ
Psychopharmacology (Berl); 1994 Sep; 116(1):1-8. PubMed ID: 7862920
[TBL] [Abstract][Full Text] [Related]
12. Medial septal lesions in rats enhance locomotor sensitization to amphetamine.
Kelsey JE; Grabarek JA
Psychopharmacology (Berl); 1999 Oct; 146(3):233-40. PubMed ID: 10541722
[TBL] [Abstract][Full Text] [Related]
13. Sensitization and individual differences to IP amphetamine, cocaine, or caffeine following repeated intracranial amphetamine infusions.
Hooks MS; Jones GH; Liem BJ; Justice JB
Pharmacol Biochem Behav; 1992 Nov; 43(3):815-23. PubMed ID: 1448477
[TBL] [Abstract][Full Text] [Related]
14. Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice.
El-Ghundi MB; Fan T; Karasinska JM; Yeung J; Zhou M; O'Dowd BF; George SR
Psychopharmacology (Berl); 2010 Jan; 207(4):599-618. PubMed ID: 19830406
[TBL] [Abstract][Full Text] [Related]
15. Individual differences in amphetamine sensitization: dose-dependent effects.
Hooks MS; Jones GH; Neill DB; Justice JB
Pharmacol Biochem Behav; 1992 Jan; 41(1):203-10. PubMed ID: 1539070
[TBL] [Abstract][Full Text] [Related]
16. Clozapine pre-treatment has a protracted hypolocomotor effect on the induction and expression of amphetamine sensitization.
Herrera AS; Casanova JP; Gatica RI; Escobar F; Fuentealba JA
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():1-6. PubMed ID: 23954739
[TBL] [Abstract][Full Text] [Related]
17. The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations.
Feldpausch DL; Needham LM; Stone MP; Althaus JS; Yamamoto BK; Svensson KA; Merchant KM
J Pharmacol Exp Ther; 1998 Jul; 286(1):497-508. PubMed ID: 9655895
[TBL] [Abstract][Full Text] [Related]
18. D(3) dopamine receptors are down-regulated in amphetamine sensitized rats and their putative antagonists modulate the locomotor sensitization to amphetamine.
Chiang YC; Chen PC; Chen JC
Brain Res; 2003 May; 972(1-2):159-67. PubMed ID: 12711089
[TBL] [Abstract][Full Text] [Related]
19. Startle and sensorimotor gating in rats lacking CCK-A receptors.
Feifel D; Priebe K; Shilling PD
Neuropsychopharmacology; 2001 Jun; 24(6):663-70. PubMed ID: 11331146
[TBL] [Abstract][Full Text] [Related]
20. Effects of intracerebroventricular administration of the CCK(1) receptor antagonist devazepide on food intake in rats.
Ebenezer IS
Eur J Pharmacol; 2002 Apr; 441(1-2):79-82. PubMed ID: 12007923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
